A Phase II Placebo-controlled Intervention Trial of Oral N-acetylcysteine (NAC) for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Overview
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- University of Utah
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- UV-induced Oxidative Stress in Irradiated and Unirradiated Nevi
Overview
Brief Summary
This is a phase II intervention to propose a new melanoma chemoprevention agent. The investigators believe oxidative stress/damage in nevi is a probable indication for melanoma risk, and propose that reduced melanoma risk in humans can be inferred by protection of nevi from ultraviolet light (UV)-induced oxidative changes. The investigators will 1) evaluate whether administration of NAC around the time of UV exposure will reduce melanoma risk in high-risk patient populations with genetic susceptibility to UV-induced oxidative stress, and 2) examine key genetic variants that will identify which individuals are most likely to benefit from chemoprotection.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Triple (Participant, Care Provider, Investigator)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Must have at least 2 nevi (each \>6 mm diameter) not clinically suspicious for melanoma that can be biopsied.
- •Must be able to receive informed consent and sign an approved consent form that conforms to federal and institutional guidelines.
Exclusion Criteria
- •The patient is a minor (\< 18 years old).
- •The patient cannot speak/understand English or Spanish. (NOTE: A Spanish consent form and certified interpreter can be made available if needed)
- •The patient is pregnant. (NOTE: All female patients who have not had a hysterectomy and are not post-menopausal (i.e. post-menopausal for 1 year and not of child-bearing potential) will have a urine pregnancy test.)
- •The patient is a prisoner, critically or mentally ill, or otherwise incapacitated or considered vulnerable.
- •The patient has history of allergic reaction to NAC.
- •The patient has history of severe asthma.
- •The patient has been taking NAC or any other oral antioxidant.
- •The patient has recent history (i.e., 3 months) of sunless tanning (tanning bed) or extensive sunburn.
Arms & Interventions
Patients receiving N-acetylcysteine
Patients receiving NAC (N-acetylcysteine)
Intervention: N-acetylcysteine (Drug)
Placebo Group
Participants not receiving NAC (N-acetylcysteine)
Intervention: Placebo arm (Other)
Outcomes
Primary Outcomes
UV-induced Oxidative Stress in Irradiated and Unirradiated Nevi
Time Frame: 3.5 years
Differences in the median percent nevus with 8-OG expression in UV-irradiated nevi compares with unirradiated nevi.
Secondary Outcomes
- Transcriptional Markers of UV-induced Oxidative Stress in Nevi(3.5 years)